ACAT1 and cardiovascular disorder: However research in models of Alzheimer’s and cardiovascular disease has shown that excessive CE formation leads to the activation of myeloid cells and subsequently to cellular damage and that this can be blocked by inhibiting ACAT1/SOAT1 activity55–57.